Axsome Therapeutics Files 8-K
Ticker: AXSM · Form: 8-K · Filed: Mar 5, 2025 · CIK: 1579428
| Field | Detail |
|---|---|
| Company | Axsome Therapeutics, INC. (AXSM) |
| Form Type | 8-K |
| Filed Date | Mar 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
Related Tickers: AXSM
TL;DR
AXSM filed an 8-K on 3/5/25 - check for updates.
AI Summary
Axsome Therapeutics, Inc. filed an 8-K on March 5, 2025, to report other events and financial statements. The filing does not contain specific details about the nature of these events or financial figures within the provided text.
Why It Matters
This filing indicates that Axsome Therapeutics has made a regulatory submission to the SEC, which could contain important updates for investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural document without immediate disclosed financial impact or significant operational changes.
Key Players & Entities
- Axsome Therapeutics, Inc. (company) — Registrant
- March 05, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-37635 (identifier) — Commission File Number
- 45-4241907 (identifier) — IRS Employer Identification No.
- One World Trade Center, 22nd Floor (address) — Principal Executive Offices
- New York (location) — City of Principal Executive Offices
- 10007 (zip_code) — Zip Code of Principal Executive Offices
- (212) 332-3241 (phone_number) — Registrant's Telephone Number
FAQ
What specific events are being reported in this 8-K filing?
The filing indicates 'Other Events' and 'Financial Statements and Exhibits' as items being reported, but the specific details are not provided in the text.
When was this 8-K report filed?
The report was filed on March 5, 2025.
What is the exact name of the company filing this report?
The exact name of the company is Axsome Therapeutics, Inc.
In which state was Axsome Therapeutics, Inc. incorporated?
Axsome Therapeutics, Inc. was incorporated in Delaware.
What is the principal executive office address for Axsome Therapeutics, Inc.?
The principal executive office is located at One World Trade Center, 22nd Floor, New York, New York, 10007.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 5, 2025 regarding Axsome Therapeutics, Inc. (AXSM).